Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:disease
|
| gptkbp:canProgressTo |
gptkb:chronic_Hepatitis_C
|
| gptkbp:causedBy |
gptkb:Hepatitis_C_virus
|
| gptkbp:complication |
liver failure
fulminant hepatitis |
| gptkbp:diagnosedBy |
HCV RNA test
antibody test |
| https://www.w3.org/2000/01/rdf-schema#label |
acute Hepatitis C
|
| gptkbp:ICD-10_code |
B17.1
|
| gptkbp:onset |
2 to 12 weeks after exposure
|
| gptkbp:prevalence |
less common than chronic Hepatitis C
|
| gptkbp:prevention |
safe injection practices
screening blood products |
| gptkbp:symptom |
nausea
abdominal pain fatigue jaundice loss of appetite dark urine |
| gptkbp:transmissionRoute |
blood-to-blood contact
sharing needles unsafe medical procedures |
| gptkbp:treatment |
gptkb:insulin
direct-acting antivirals ribavirin |
| gptkbp:bfsParent |
gptkb:Hepatitis_C
|
| gptkbp:bfsLayer |
5
|